Hypoglycaemia risk increases when GLP-1 agonists are combined with sulphonylureas or insulin, requiring dose adjustments
Systematic monitoring helps you determine whether the reset worked and guides decisions about dose titration when restarting
In four randomized controlled trials (RCT) conducted in patients with obesity without T2D 15,16,17,18 , liraglutide 3.0 mg was compared to placebo as an adjunct to lifestyle optimization over 56 weeks, with the exception of the 3-year extension of the SCALE Obesity and Prediabetes study
We'll verify your coverage and show you exactly what's included no surprises
Protein recommendations for older adults and during weight loss
The perception of "ruined metabolism" often stems from the challenge of maintaining weight loss after discontinuation, which reflects the complex biology of weight regulation rather than drug-induced harm